Search Results - "Crossey, M M E"

Hepatic steatosis and fibrosis: Non-invasive assessment by Karanjia, Rustam N, Crossey, Mary M E, Cox, I Jane, Fye, Haddy K S, Njie, Ramou, Goldin, Robert D, Taylor-Robinson, Simon D

“…Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and…”
Get full text

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy by Bajaj, Jasmohan S., Gillevet, Patrick M., Patel, Neeral R., Ahluwalia, Vishwadeep, Ridlon, Jason M, Kettenmann, Birgit, Schubert, Christine M., Sikaroodi, Masoumeh, Heuman, Douglas M., Crossey, Mary M. E., Bell, Debulon E., Hylemon, Philip B., Fatouros, Panos P., Taylor-Robinson, Simon D.

“…The pathogenesis of hepatic encephalopathy(HE) is unclear. However gut flora changes, inflammation and neuro-glial injury have been implicated. The aim was to…”
Get full text

Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study by Grover, Vijay P. B., Crossey, Mary M. E., Fitzpatrick, Julie A., Saxby, Brian K., Shaw, Roberta, Waldman, Adam D., Morgan, Marsha Y., Taylor-Robinson, Simon D.

“…Cerebral magnetic resonance imaging was undertaken, at 3 Tesla field strength, employing magnetization transfer (MT) and diffusion-weighted imaging (DWI)…”
Get full text

Hepatocellular carcinoma: Review of disease and tumor biomarkers by Kim, Jin Un, Shariff, Mohamed I F, Crossey, Mary M E, Gomez-Romero, Maria, Holmes, Elaine, Cox, I Jane, Fye, Haddy K S, Njie, Ramou, Taylor-Robinson, Simon D

“…Hepatocellular carcinoma(HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and…”
Get full text

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy by Grover, Vijay P. B., McPhail, Mark J. W., Wylezinska-Arridge, Marzena, Crossey, Mary M. E., Fitzpatrick, Julie A., Southern, Louise, Saxby, Brian K., Cook, Nicola A., Cox, I. Jane, Waldman, Adam D., Dhanjal, Novraj S., Bak-Bol, Aluel, Williams, Roger, Morgan, Marsha Y., Taylor-Robinson, Simon D.

“…The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety…”
Get full text

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency by Sheridan, David A., Bridge, S. H., Crossey, M. M. E., Felmlee, D. J., Thomas, H. C., Neely, R. D. G., Taylor-Robinson, S. D., Bassendine, M. F.

“…Neuro-psychiatric and cognitive disorders are frequent in patients with chronic hepatitis C (CHC) virus (HCV) infection which adversely impact quality of life,…”
Get full text

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function by Bajaj, Jasmohan S, Cox, I Jane, Betrapally, Naga S, Heuman, Douglas M, Schubert, Mitchell L, Ratneswaran, Maiyuran, Hylemon, Phillip B, White, Melanie B, Daita, Kalyani, Noble, Nicole A, Sikaroodi, Masoumeh, Williams, Roger, Crossey, Mary M E, Taylor-Robinson, Simon D, Gillevet, Patrick M

“…Proton pump inhibitors (PPI) have been associated with infectious complications in cirrhosis, but their impact on distal gut microbiota composition and…”
Get more information

Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C by Cobbold, Jeremy F. L., Patel, Dhupal, Fitzpatrick, Julie A., Patel, Nayna, Crossey, Mary M. E., AbdAlla, Mohamed Saad, Goldin, Robert D., Vennart, William, Thomas, Howard C., Taylor-Robinson, Simon D.

“…Aim:  Contrast‐enhanced ultrasound can be used to assess liver disease severity non‐invasively by observing intra‐ and extrahepatic hemodynamic changes…”
Get full text

Challenges of liver cancer:Future emerging tools in imaging and urinary biomarkers by Trovato, Francesca M, Tognarelli, Joshua M, Crossey, Mary Me, Catalano, Daniela, Taylor-Robinson, Simon D, Trovato, Guglielmo M

“…Chronic liver disease has become a global health problem as a result of the increasing incidence of viral hepatitis, obesity and alcohol misuse. Over the past…”
Get full text

Urinary Metabolic Biomarkers of Hepatocellular Carcinoma in an Egyptian Population: A Validation Study by Shariff, Mohamed I. F, Gomaa, Asmaa I, Cox, I. Jane, Patel, Madhvi, Williams, Horace R. T, Crossey, Mary M. E, Thillainayagam, Andrew V, Thomas, Howard C, Waked, Imam, Khan, Shahid A, Taylor-Robinson, Simon D

“…The advent of metabonomics has seen a proliferation of biofluid profiling studies of patients with hepatocellular carcinoma. The majority of these studies have…”
Get full text

Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans by Ladep, Nimzing G., Dona, Anthony C., Lewis, Matthew R., Crossey, Mary M.E., Lemoine, Maud, Okeke, Edith, Shimakawa, Yusuke, Duguru, Mary, Njai, Harr F., Fye, Haddy K.S., Taal, Makie, Chetwood, John, Kasstan, Ben, Khan, Shahid A., Garside, Deborah A., Wijeyesekera, Anisha, Thillainayagam, Andrew V., Banwat, Edmund, Thursz, Mark R., Nicholson, Jeremy K., Njie, Ramou, Holmes, Elaine, Taylor‐Robinson, Simon D.

“…There is no clinically applicable biomarker for surveillance of hepatocellular carcinoma (HCC), because the sensitivity of serum alpha‐fetoprotein (AFP) is too…”
Get full text

Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study by Cox, I Jane, Aliev, Abil E, Crossey, Mary Me, Dawood, Mahvish, Al-Mahtab, Mamun, Akbar, Sheikh M, Rahman, Salimur, Riva, Antonio, Williams, Roger, Taylor-Robinson, Simon D

“…AIM: To establish if a distinct urinary metabolic profile could be identified in Bangladeshi hepatitis-B hepatocellular carcinoma(HCC) patients compared to…”
Get full text

Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity by Sheridan, David A, Bridge, Simon H, Felmlee, Daniel J, Crossey, Mary M.E, Thomas, Howard C, Taylor-Robinson, Simon D, Toms, Geoffrey L, Neely, R. Dermot G, Bassendine, Margaret F

“…Background & Aims Hepatitis C virus (HCV) interacts with apolipoproteins B (apoB) and E (apoE) to form infectious lipoviral particles (LVP). Response to…”
Get full text

Characterization of Urinary Biomarkers of Hepatocellular Carcinoma Using Magnetic Resonance Spectroscopy in a Nigerian Population by Shariff, Mohamed I. F, Ladep, Nimzing G, Cox, I. Jane, Williams, Horace R. T, Okeke, Edith, Malu, Abraham, Thillainayagam, Andrew V, Crossey, Mary M. E, Khan, Shahid A, Thomas, Howard C, Taylor-Robinson, Simon D

“…Hepatocellular carcinoma (HCC) is the commonest primary hepatic malignancy worldwide. Current serum diagnostic biomarkers, such as α-fetoprotein, are expensive…”
Get full text

Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients by Wozniak, M. A., Lugo Iparraguirre, L. M., Dirks, M., Deb-Chatterji, M., Pflugrad, H., Goldbecker, A., Tryc, A. B., Worthmann, H., Gess, M., Crossey, M. M. E., Forton, D. M., Taylor-Robinson, S. D., Itzhaki, R. F., Weissenborn, K.

“…Summary Hepatitis C virus (HCV) causes not only liver damage in certain patients but can also lead to neuropsychiatric symptoms. Previous studies have shown…”
Get full text

Modulation of neural activation following treatment of hepatic encephalopathy by MCPHAIL, Mark J. W, LEECH, Robert, WALDMAN, Adam D, THOMAS, Howard C, TAYLOR-ROBINSON, Simon D, GROVER, Vijay P. B, FITZPATRICK, Julie A, DHANJAL, Novraj S, CROSSEY, Mary M. E, PFLUGRAD, Henning, SAXBY, Brian K, WESNES, Keith, DRESNER, M. Alex

“…To measure changes in psychometric state, neural activation, brain volume (BV), and cerebral metabolite concentrations during treatment of minimal hepatic…”
Get full text

Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy study by Cobbold, Jeremy F.L, Patel, Jaymin H, Goldin, Robert D, North, Bernard V, Crossey, Mary M.E, Fitzpatrick, Julie, Wylezinska, Marzena, Thomas, Howard C, Cox, I. Jane, Taylor-Robinson, Simon D

“…Background & Aims Hepatic steatosis is an important factor in pathogenesis, progression and response to treatment in hepatitis C. We aimed to investigate…”
Get full text

Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial by Sheridan, David A., Bridge, Simon H., Crossey, Mary M. E., Felmlee, Daniel J., Fenwick, Fiona I., Thomas, Howard C., Neely, R. Dermot G., Taylor-Robinson, Simon D., Bassendine, Margaret F.

“…Background & Aims Hepatitis C virus (HCV) utilises cholesterol and lipoprotein metabolism for replication and infectivity. Statins and omega‐3 (n–3)…”
Get full text

Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians by Grover, Vijay P.B, Tognarelli, Joshua M, Crossey, Mary M.E, Cox, I. Jane, Taylor-Robinson, Simon D, McPhail, Mark J.W

“…The development of magnetic resonance imaging (MRI) for use in medical investigation has provided a huge forward leap in the field of diagnosis, particularly…”
Get full text

Incidence and mortality of primary liver cancer in England and Wales: Changing patterns and ethnic variations by Ladep, Nimzing G, Khan, Shahid A, Crossey, Mary Me, Thillainayagam, Andrew V, Taylor-Robinson, Simon D, Toledano, Mireille B

“…AIM: To explore recent trends, modes of diagnosis, ethnic distribution and the mortality to incidence ratio of primary liver cancer by subtypes in England and…”
Get full text